Oceanpine Healthcare Fund
Oceanpine Healthcare Fund is a Beijing-based venture capital firm established in 2016, focusing on the healthcare sector. The fund aims to connect innovative healthcare solutions from the United States with the Chinese consumer market. It primarily invests in biotech, medical devices, innovative drug discovery, genome sequencing, in-vitro diagnostics, and artificial intelligence. By addressing the supply and demand gap in China, which is hindered by limited research and development, Oceanpine employs a "Dual Market" strategy to support its portfolio companies. This approach provides local resources and guidance, facilitating growth and development while offering investors diversification and enhanced value realization.
Refuge Biotechnologies, Inc. is a Menlo Park, California-based company focused on developing cancer immunotherapies. Established in 2015, it utilizes synthetic biology and gene-editing technology, specifically CRISPR-dCas, to create innovative treatments. The company's approach involves engineering cell therapies that can sense their environment and simultaneously activate or repress multiple genes. This strategy aims to enhance the effectiveness and precision of cancer treatments, moving beyond traditional methods that target a single function. Through its research and development efforts, Refuge Biotechnologies is dedicated to advancing cancer diagnostics and therapies to improve patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.